Cutler Group LP Chimerix Inc Transaction History

Cutler Group LP

  • $307 Million
  • Q1 2024

A detailed history of Cutler Group LP transactions in Chimerix Inc stock. As of the latest transaction made, Cutler Group LP holds 7,400 shares of CMRX stock, worth $63,195. This represents 0.0% of its overall portfolio holdings.

Number of Shares
7,400
Previous 7,400 -0.0%
Holding current value
$63,195
Previous $7,000 -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

Apr 26, 2021
SELL
$4.76 - $11.25 $952 - $2,250
-200 Reduced 2.63%
7,400 $71,000
Q3 2017

Oct 17, 2017
BUY
$4.35 - $5.25 $33,060 - $39,900
7,600
7,600 $39,000

Others Institutions Holding CMRX

# of Institutions
10
Shares Held
1.89M
Call Options Held
0
Put Options Held
0
View Full List

About CHIMERIX INC

CMRX Quotes by TradingView
  • Ticker CMRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 87,622,896
  • Market Cap $748M
  • Description
  • Chimerix, Inc., a biopharmaceutical company, develops medicines to enhance the lives of patients living with serious diseases. The company's approved product is TEMBEXA (brincidofovir), a lipid conjugate through inhibition of viral DNA synthesis that is developed as a medical countermeasure for smallpox. Its clinical stage development programs i...
More about CMRX
Track This Portfolio

Track Cutler Group LP Portfolio

Follow Cutler Group LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

News

Stay updated on Cutler Group LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email